Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Ceramides wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
2 of 2 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
350mg wheat-derived ceramides or 30-40mg glycosphingolipids daily
Once daily with food
Wheat-derived phytoceramides (Ceramide-PCD)
Liquid EPs 7630: 30 drops three times daily for adults during an acute infection
spread-through-day
Liquid extract (EPs 7630)
4-8 weeks
8-12 weeks
4-8 weeks
Days 4-7 of an acute episode
Within the acute illness window
During use
Ceramides and depression: A systematic review
Journal of affective disorders (2017) · Systematic review · n=14
Pharmacotherapy targeting ceramide metabolism may be a novel treatment option for depression.
Effect of oral intake of phytoceramides on skin hydration: A systematic review and meta-analysis of clinical studies
Journal of Cosmetic Dermatology (2021) · Meta analysis · n=542
Oral phytoceramides significantly increased skin hydration measured by corneometry
Oral supplementation with plant-derived ceramides improves skin barrier function and reduces skin dryness: A randomized, double-blind, placebo-controlled trial
Journal of the European Academy of Dermatology and Venereology (2017) · Rct · n=66
Skin hydration was significantly improved after 60 days of phytoceramide supplementation
Pelargonium sidoides extract for treating acute respiratory tract infections.
Cochrane Database Syst Rev (2013) · Systematic review · n=10 trials; ~746 adults and ~819 children
Liquid EPs 7630 showed effectiveness for acute bronchitis in both adults and children; tablets did not
Treatment of acute bronchitis with EPs 7630: randomized, controlled trial in children and adolescents.
Pediatr Int (2012) · Rct · n=220 children/adolescents
Significantly greater BSS reduction with EPs 7630 versus placebo (P<0.0001)
Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides.
Wien Med Wochenschr (2010) · Rct · n=406 adults
All three active dose groups improved patient-reported outcomes versus placebo at day 7
Ceramides has a higher evidence score (9/10 vs 5/10) and wins in 3 of 3 categories.
No known interactions between Ceramides and Pelargonium Sidoides have been documented in our database. However, always consult a healthcare provider before combining supplements.